BioROSA Technologies Inc.
Creating a biologically-based diagnostic standard of care for autism spectrum disorders
Operating in diagnostics based in BELMONT, MASSACHUSETTS, BioROSA Technologies Inc. was founded in 2017.
Profile
Over 30 million children and over 100 million people around the world live with autism spectrum disorders (ASD). BioROSA is challenging the status quo by developing cost-effective, fast, and simple diagnostic tools to allow clinicians to easily determine who is at risk for ASD, simplify the diagnostic process, and enable therapeutic developments. We do this through powerful blood-based biomarkers and machine learning tools.
Within the diagnostics space, the company focuses on its core offering rather than a broad product line.
The company is recorded as being based in BELMONT, MASSACHUSETTS.
Directory data places it at the Regulation D stage.
The company reports a headcount in the 2-10 range.
Public records show total funding of about $1M.
| Sector | Diagnostics |
|---|---|
| Headquarters | BELMONT, MASSACHUSETTS |
| Country | United States |
| Founded | 2017 |
| Employees | 2-10 |
| Stage | Regulation D |
| Total funding | $1,000,000 |
Website: biorosa.com
Create a free account